A novel, rapid method to detect infectious HIV-1 from plasma of persons infected with HIV-1
- PMID: 20117138
- DOI: 10.1016/j.jviromet.2010.01.010
A novel, rapid method to detect infectious HIV-1 from plasma of persons infected with HIV-1
Abstract
Efficient isolation of replication-competent virus from plasma of patients infected with HIV-1 is needed to characterize important clinical parameters of virus. However, addition of plasma to in vitro cultures results in clot formation. Blood from HIV-1 infected patients was collected in the presence of three commonly used anticoagulants (ACD, heparin and EDTA) and plasma was isolated. Plasma was then used to infect HIV-1 indicator cell lines (TZM-bl and GHOST) with spinoculation in the presence or absence of additional heparin and positively charged polymers. The presence of additional heparin during inoculation significantly reduced clot formation without affecting the sensitivity of HIV-1 infection in the GHOST cell line. However, heparin reduced the frequency of HIV-1 infection of the TZM-bl cell line. Using plasma from patients with HIV RNA>1000 copies/ml (n=58), the frequency of HIV-1 isolation was 92% in GHOST (n=51) and 54% in TZM-bl (n=26) cell lines. A sensitive method was developed for rapid isolation of infectious HIV-1 from plasma of patients with HIV RNA>1000 copies/ml that includes spinoculation and the addition of heparin during infection of GHOST cells. This technique could be used for rapid evaluation of viral fitness, co-receptor usage or drug resistance without the need for viral amplification.
Copyright (c) 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Generation of HIV-1 primary isolates representative of plasma variants using the U87.CD4 cell line.J Virol Methods. 2010 Nov;169(2):341-50. doi: 10.1016/j.jviromet.2010.08.001. Epub 2010 Aug 10. J Virol Methods. 2010. PMID: 20705104
-
Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol.Virology. 2004 Aug 15;326(1):113-29. doi: 10.1016/j.virol.2004.05.022. Virology. 2004. PMID: 15262500
-
HIV-1 isolation from small amounts of whole blood: a technical evaluation.Microbiologica. 1992 Jan;15(1):35-44. Microbiologica. 1992. PMID: 1556958
-
Molecular biological assessment methods and understanding the course of the HIV infection.APMIS Suppl. 2003;(114):1-37. APMIS Suppl. 2003. PMID: 14626050 Review.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
Cited by
-
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.Nature. 2013 Nov 14;503(7475):224-8. doi: 10.1038/nature12744. Epub 2013 Oct 30. Nature. 2013. PMID: 24172905 Free PMC article.
-
Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients.Pathogens. 2020 Dec 13;9(12):1047. doi: 10.3390/pathogens9121047. Pathogens. 2020. PMID: 33322208 Free PMC article.
-
Genetic characterization of natural variants of Vpu from HIV-1 infected individuals from Northern India and their impact on virus release and cell death.PLoS One. 2013;8(3):e59283. doi: 10.1371/journal.pone.0059283. Epub 2013 Mar 28. PLoS One. 2013. PMID: 23555649 Free PMC article.
-
Design, Synthesis, and Biological Evaluation of 1,2-Dihydroisoquinolines as HIV-1 Integrase Inhibitors.ACS Med Chem Lett. 2015 Aug 10;6(10):1065-70. doi: 10.1021/acsmedchemlett.5b00230. eCollection 2015 Oct 8. ACS Med Chem Lett. 2015. PMID: 26487913 Free PMC article.
-
HIV-1 Vpr redirects host ubiquitination pathway.J Virol. 2014 Aug;88(16):9141-52. doi: 10.1128/JVI.00619-14. Epub 2014 Jun 4. J Virol. 2014. PMID: 24899191 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
